FDA Inspection
Pyramid Laboratories, Inc.Pyramid Laboratories, Inc. – FDA Inspection, Feb 13, 2026
Record Details
This FDA Inspection record concerns Pyramid Laboratories, Inc., with an inspection on February 13, 2026, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · f8544aaf-879a-408f-8837-83bf1b8673eb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1303644
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.65(a)Equipment construction - reactive surfaces
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pyramid Laboratories, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2019 | Not classified | Los Angeles District Office | New Drug Evaluation |
| April 2, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 5, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 15, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pyramid Laboratories, Inc.
- FDA Inspection 1153303 - 2021-09-29
- FDA Inspection 1085965 - 2019-04-11
- FDA Inspection 1050366 - 2018-04-02
- FDA Inspection 929256 - 2015-06-05
- FDA Inspection 910747 - 2015-01-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.